These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32729220)

  • 1. Circulating tumor DNA in neuroblastoma.
    Wei M; Ye M; Dong K; Dong R
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28311. PubMed ID: 32729220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies.
    Valpione S; Campana L
    Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.
    Watanabe F; Suzuki K; Tamaki S; Abe I; Endo Y; Takayama Y; Ishikawa H; Kakizawa N; Saito M; Futsuhara K; Noda H; Konishi F; Rikiyama T
    PLoS One; 2019; 14(12):e0227366. PubMed ID: 31891652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific genetic variants can be detected in circulating cell-free DNA of malignant pleural mesothelioma patients.
    Hylebos M; Op de Beeck K; Pauwels P; Zwaenepoel K; van Meerbeeck JP; Van Camp G
    Lung Cancer; 2018 Oct; 124():19-22. PubMed ID: 30268460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy: unlocking the potentials of cell-free DNA.
    Chu D; Park BH
    Virchows Arch; 2017 Aug; 471(2):147-154. PubMed ID: 28466157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma.
    Mohammadi M; Goodarzi M; Jaafari MR; Mirzaei HR; Mirzaei H
    Cancer Gene Ther; 2016 Nov; 23(11):371-372. PubMed ID: 27740613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Circulating Tumor DNA for Cancer Immunotherapy.
    Snyder A; Morrissey MP; Hellmann MD
    Clin Cancer Res; 2019 Dec; 25(23):6909-6915. PubMed ID: 31285372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing circulating tumor DNA analysis in a clinical laboratory: A user manual.
    Koessler T; Addeo A; Nouspikel T
    Adv Clin Chem; 2019; 89():131-188. PubMed ID: 30797468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors.
    van Zogchel LMJ; Lak NSM; Verhagen OJHM; Tissoudali A; Gussmalla Nuru M; Gelineau NU; Zappeij-Kannengieter L; Javadi A; Zijtregtop EAM; Merks JHM; van den Heuvel-Eibrink M; Schouten-van Meeteren AYN; Stutterheim J; van der Schoot CE; Tytgat GAM
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34820594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cornerstone of integrating circulating tumor DNA into cancer management.
    Li Z; Yi L; Gao P; Zhang R; Li J
    Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):1-11. PubMed ID: 30419316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Circulating Nucleic Acid Characteristics of Non-Metastatic Soft Tissue Sarcoma Patients.
    Eastley N; Sommer A; Ottolini B; Neumann R; Luo JL; Hastings RK; McCulloch T; Esler CP; Shaw JA; Ashford RU; Royle NJ
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells in neuroblastoma: Current status and future perspectives.
    Yang R; Zheng S; Dong R
    Cancer Med; 2023 Jan; 12(1):7-19. PubMed ID: 35632981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies.
    Abbou SD; Shulman DS; DuBois SG; Crompton BD
    Pediatr Blood Cancer; 2019 May; 66(5):e27595. PubMed ID: 30614191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Introduction and Clinical Application of Cell-Free Tumor DNA.
    Li J; Liu R; Huang C; Chen S; Xu M
    Methods Mol Biol; 2018; 1754():45-65. PubMed ID: 29536437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients.
    Van Roy N; Van Der Linden M; Menten B; Dheedene A; Vandeputte C; Van Dorpe J; Laureys G; Renard M; Sante T; Lammens T; De Wilde B; Speleman F; De Preter K
    Clin Cancer Res; 2017 Oct; 23(20):6305-6314. PubMed ID: 28710315
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioinformatics Analysis for Cell-Free Tumor DNA Sequencing Data.
    Chen S; Liu M; Zhou Y
    Methods Mol Biol; 2018; 1754():67-95. PubMed ID: 29536438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment and Analysis of ctDNA.
    Gilson P
    Recent Results Cancer Res; 2020; 215():181-211. PubMed ID: 31605230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.
    Kuroda T; Saeki M; Nakano M; Mizutani S
    J Pediatr Surg; 1997 Jan; 32(1):69-72. PubMed ID: 9021573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma.
    Kim YM; Lee SW; Lee YJ; Lee HY; Lee JE; Choi EK
    J Gynecol Oncol; 2019 May; 30(3):e32. PubMed ID: 30887755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Noninvasive Detection of Response to Targeted Therapy in Non-Small Cell Lung Cancer.
    Phallen J; Leal A; Woodward BD; Forde PM; Naidoo J; Marrone KA; Brahmer JR; Fiksel J; Medina JE; Cristiano S; Palsgrove DN; Gocke CD; Bruhm DC; Keshavarzian P; Adleff V; Weihe E; Anagnostou V; Scharpf RB; Velculescu VE; Husain H
    Cancer Res; 2019 Mar; 79(6):1204-1213. PubMed ID: 30573519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.